BNB Plus Corp. received a delisting notice from Nasdaq, resulting in the suspension of trading of its common stock on the Nasdaq Capital Market effective July 14, 2026. The delisting follows the company's failure to satisfy the $1.00 minimum bid price requirement. Although the company requested a hearing and an extension, the Nasdaq Hearings Panel declined the extension. The company intends to request a review by the Nasdaq Listing and Hearing Review Council. BNB Plus Corp. expects its common stock to begin trading on the OTCQB Venture Market under the symbol BNBX on July 14, 2026. The company operates in the health sciences sector.
